27
Participants
Start Date
May 10, 2021
Primary Completion Date
July 27, 2021
Study Completion Date
July 27, 2021
gadopiclenol
administration by intravenous (IV) bolus injection at 2 mL/s rate without dilution, followed by a saline flush of at least 5 mL at the same rate to ensure complete injection of the contrast agent.The gadopiclenol administration is performed by power injecto
Placebo
intravenous (IV) bolus injection at 2 mL/s, followed by a saline flush of at least 5 mL to be in the same conditions as for gadopiclenol administration.The gadopiclenol administration is performed by power injector
Hataka clinic, Fukuoka
Lead Sponsor
Guerbet
INDUSTRY